tm
Seeing Is Believing
tm
Seeing Is Believing
Prevail Therapeutics's activity chart (see below) currently has 16 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 68% with an average time for these price targets to be met of 199.2 days.
Most recent stock forecast was given by from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Jul-2019
$22
$-1 (-4.35%)
$22
5 years 8 months 22 days ago
(23-Dec-2020)
2/5 (40%)
$-1.18 (-5.09%)
234
Buy Since 16-Jul-2020
$23
5 years 8 months 28 days ago
(17-Dec-2020)
2/2 (100%)
$-0.17 (-0.73%)
84
Buy Since 06-Mar-2020
$24
$1 (4.35%)
5 years 8 months 30 days ago
(15-Dec-2020)
0/2 (0%)
$1.25 (5.49%)
Buy Since 09-Apr-2020
6 years 1 months 3 days ago
(11-Aug-2020)
2/2 (100%)
$4.12 (25.94%)
241
Buy Since 15-Jul-2019
$20
$-3 (-13.04%)
$20
6 years 8 months 18 days ago
(27-Dec-2019)
2/2 (100%)
$4.19 (26.50%)
437
What is PRVL (Prevail Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PRVL (Prevail Therapeutics)?
Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?
Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?
Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?
